ArticleInternational journal of women's health2023
Rare Vulvar Angiomyofibroblastoma: Case Series and Literature Review.
Article in International journal of women's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 5 citations in OpenAlex.
- Management of a large angiomyofibroblastoma of the vulva: a case report describing radical excision and reconstruction.Case reports in women's health · 2026Article
- Case Report: A Rare Recurrent Vaginal Angiomyofibroblastoma.Journal of clinical ultrasound : JCU · 2026Article
- Angiomyofibroblastoma of the vulva in a 29-year-old woman: a case report of a rare entity with successful vaginal delivery.BMC pregnancy and childbirth · 2026Article
- Vulvar angiomyofibroblastoma misdiagnosed as subcutaneous lipoma: a case report and literature review.Frontiers in medicine · 2026Article
- Pedunculated angiomyofibroblastoma of the vulva.Archives of gynecology and obstetrics · 2024Article
- Angiomyofibroblastoma as a rare cause of vulvar mass: A case report and literature review.Clinical case reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Angiomyofibroblastoma (AMFB) is an uncommon disease with few literature reports, leading to the poor understanding of its diagnosis, treatment, and postoperative follow-up plans among gynecologists. Objective: To study the clinical and pathological features of vulvar AMFB and discuss its treatment and prognosis. Case Summary: The 3 cases were characterized by a gradually increasing painless mass in the vulva. Preoperative diagnosis was difficult and mainly depended on ultrasonic examination. Immunohistochemistry confirmed clear boundaries of AMFB. This condition could be completely cured by surgery, and the prognosis was good. Conclusion: The vulvar AMFB is a rare tumor that is frequently misdiagnosed before surgery. Ultrasound is preferred in auxiliary diagnosis, and surgery remains the best treatment, and long-term follow-up is necessary to avoid recurrence or other complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.